Published in Drug Week, January 28th, 2005
After 1-month exposure, only the high dose of Progenta achieved a statistically significant reduction of fibroid size as compared to baseline. Patients on the highest dose of Progenta experienced a statistically significant reduction in fibroid size of 24.2%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.